References
- O'Brien P MS. The premenstrual syndrome: A review of the present status of therapy. Drugs 1982; 24: 140–51
- Kerr G D. The management of the premenstrual syndrome. Curr Med Res Opin 1977; 4: 29–35
- Day J B. Clinical trials in the premenstrual syndrome. Curr Med Res Opin 1979; 6: 40–6
- Stokes J, Mendels J. Pyridoxine and premenstrual tension. Lancet 1972; i: 1177–8
- Abraham G E., Hargrove J T. Effect of vitamin B-6 on premenstrual symptomatology in women with premenstrual tension syndromes: a double blind crossover study. Infertility 1980; 312: 155–65
- Abraham G E., Lubran M M. Serum and red cell magnesium levels in patients with premenstrual tension. Am J Clin Nutr 1981; 34: 2364–6
- Abraham G E., Schwartz U D., Lubran M M. Effect of vitamin B-6 on plasma and red blood cell magnesium levels in premenopausal women. Ann Clin Lab Sci 1981; ll: 333–6
- Moos R H. Typology of menstrual cycle symptoms. Am J Obstet Gynecol 1968; 103: 390–402
- Owen D B. Handbook of Statistical Tables. Addison-Wesley Public Company. 1962
- Pocock S J. Clinical Trials. A Practical Approach. John Wiley & Sons, Chichester, New York, Brisbane, TorontoSingapore 1983
- Schaumburg H, Kaplan J, Windebank A, et al. Sensory neuropathy from pyridoxine abuse. N Engl J Med 1983; 309: 445–8
- Berger A, Schaumburg H H. More on neuropathy from pyridoxine abuse. N Engl J Med 1984; 311: 986–7